Pharmacologic Approaches to the Treatment of Obstructive Sleep Apnea

Published:April 08, 2016DOI:https://doi.org/10.1016/j.jsmc.2016.01.007

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Sleep Medicine Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Eckert D.J.
        • White D.P.
        • Jordan A.S.
        • et al.
        Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets.
        Am J Respir Crit Care Med. 2013; 188: 996-1004
        • Wellman A.
        • Eckert D.J.
        • Jordan A.S.
        • et al.
        A method for measuring and modeling the physiological traits causing obstructive sleep apnea.
        J Appl Physiol. 2011; 110: 1627-1637
        • Wellman A.
        • Edwards B.A.
        • Sands S.A.
        • et al.
        A simplified method for determining phenotypic traits in patients with obstructive sleep apnea.
        J Appl Physiol. 2013; 114: 911-922
        • Newman A.B.
        • Foster G.
        • Givelber R.
        • et al.
        Progression and regression of sleep-disordered breathing with changes in weight: the Sleep Heart Health Study.
        Arch Intern Med. 2005; 165: 2408-2413
        • Trulson M.E.
        • Jacobs B.L.
        Raphe unit activity in freely moving cats: correlation with level of behavioral arousal.
        Brain Res. 1979; 163: 135-150
        • Saper C.B.
        • Scammell T.E.
        • Lu J.
        Hypothalamic regulation of sleep and circadian rhythms.
        Nature. 2005; 437: 1257-1263
        • Jelev A.
        • Sood S.
        • Liu H.
        • et al.
        Microdialysis perfusion of 5-HT into hypoglossal motor nucleus differentially modulates genioglossus activity across natural sleep-wake states in rats.
        J Physiol. 2001; 532: 467-481
        • Chan E.
        • Steenland H.W.
        • Liu H.
        • et al.
        Endogenous excitatory drive modulating respiratory muscle activity across sleep-wake states.
        Am J Respir Crit Care Med. 2006; 174: 1264-1273
        • Grace K.P.
        • Hughes S.W.
        • Horner R.L.
        Identification of the mechanism mediating genioglossus muscle suppression in REM sleep.
        Am J Respir Crit Care Med. 2013; 187: 311-319
        • Veasey S.C.
        • Panckeri K.A.
        • Hoffman E.A.
        • et al.
        The effects of serotonin antagonists in an animal model of sleep-disordered breathing.
        Am J Respir Crit Care Med. 1996; 153: 776-786
        • Carley D.W.
        • Depoortere H.
        • Radulovacki M.
        R-zacopride, a 5-HT3 antagonist/5-HT4 agonist, reduces sleep apneas in rats.
        Pharmacol Biochem Behav. 2001; 69: 283-289
        • Veasey S.C.
        • Chachkes J.
        • Fenik P.
        • et al.
        The effects of ondansetron on sleep-disordered breathing in the English bulldog.
        Sleep. 2001; 24: 155-160
        • Hanzel D.A.
        • Proia N.G.
        • Hudgel D.W.
        Response of obstructive sleep apnea to fluoxetine and protriptyline.
        Chest. 1991; 100: 416-421
        • Kraiczi H.
        • Hedner J.
        • Dahlöf P.
        • et al.
        Effect of serotonin uptake inhibition on breathing during sleep and daytime symptoms in obstructive sleep apnea.
        Sleep. 1999; 22: 61-67
        • Stradling J.
        • Smith D.
        • Radulovacki M.
        • et al.
        Effect of ondansetron on moderate obstructive sleep apnoea, a single night, placebo-controlled trial.
        J Sleep Res. 2003; 12: 169-170
        • Prasad B.
        • Radulovacki M.
        • Olopade C.
        • et al.
        Prospective trial of efficacy and safety of ondansetron and fluoxetine in patients with obstructive sleep apnea syndrome.
        Sleep. 2010; 33: 982-989
        • Marshall N.S.
        • Yee B.J.
        • Desai A.V.
        • et al.
        Two randomized placebo-controlled trials to evaluate the efficacy and tolerability of mirtazapine for the treatment of obstructive sleep apnea.
        Sleep. 2008; 3: 824-831
        • Carley D.W.
        • Olopade C.
        • Ruigt G.S.
        • et al.
        Efficacy of mirtazapine in obstructive sleep apnea syndrome.
        Sleep. 2007; 30: 35-41
        • Brownell L.G.
        • Perez-Padilla R.
        • West P.
        • et al.
        The role of protriptyline in obstructive sleep apnea.
        Bull Eur Physiopathol Respir. 1983; 19: 621-624
        • Smith P.L.
        • Haponik E.F.
        • Allen R.P.
        • et al.
        The effects of protriptyline in sleep-disordered breathing.
        Am Rev Respir Dis. 1983; 127: 8-13
        • Conway W.A.
        • Zorick F.
        • Piccione P.
        • et al.
        Protriptyline in the treatment of sleep apnoea.
        Thorax. 1982; 37: 49-53
        • Grace K.P.
        • Hughes S.W.
        • Shahabi S.
        • et al.
        K+ channel modulation causes genioglossus inhibition in REM sleep and is a strategy for reactivation.
        Respir Physiol Neurobiol. 2013; 188: 277-288
        • Grace K.P.
        • Hughes S.W.
        • Horner R.L.
        Identification of a pharmacological target for genioglossus reactivation throughout sleep.
        Sleep. 2014; 37: 41-50
        • Gleeson K.
        • Zwillich C.W.
        • White D.P.
        The influence of increasing ventilatory effort on arousal from sleep.
        Am Rev Respir Dis. 1990; 142: 295-300
        • Eckert D.J.
        • Younes M.K.
        Arousal from sleep: implications for obstructive sleep apnea pathogenesis and treatment.
        J Appl Physiol. 2014; 116: 302-313
        • Eckert D.J.
        • Malhotra A.
        • Wellman A.
        • et al.
        Trazodone increases the respiratory arousal threshold in patients with obstructive sleep apnea and a low arousal threshold.
        Sleep. 2014; 37: 811-819
        • Eckert D.J.
        • Owens R.L.
        • Kehlmann G.B.
        • et al.
        Eszopiclone increases the respiratory arousal threshold and lowers the apnoea/hypopnoea index in obstructive sleep apnoea patients with a low arousal threshold.
        Clin Sci (Lond). 2011; 120: 505-514
        • Eikermann M.
        • Eckert D.J.
        • Chamberlin N.L.
        • et al.
        Effects of pentobarbital on upper airway patency during sleep.
        Eur Respir J. 2010; 36: 569-576
        • Rosenberg R.
        • Roach J.M.
        • Scharf M.
        • et al.
        A pilot study evaluating acute use of eszopiclone in patients with mild to moderate obstructive sleep apnea syndrome.
        Sleep Med. 2007; 8: 464-470
        • Höijer U.
        • Hedner J.
        • Ejnell H.
        • et al.
        Nitrazepam in patients with sleep apnoea: a double-blind placebo-controlled study.
        Eur Respir J. 1994; 7: 2011-2015
        • Kryger M.
        • Roth T.
        • Wang-Weigand S.
        • et al.
        The effects of ramelteon on respiration during sleep in subjects with moderate to severe chronic obstructive pulmonary disease.
        Sleep Breath. 2009; 13: 79-84
        • Wang D.
        • Marshall N.S.
        • Duffin J.
        • et al.
        Phenotyping interindividual variability in obstructive sleep apnoea response to temazepam using ventilatory chemoreflexes during wakefulness.
        J Sleep Res. 2011; 20: 526-532
        • Lofaso F.
        • Goldenberg F.
        • Thebault C.
        • et al.
        Effect of zopiclone on sleep, night-time ventilation, and daytime vigilance in upper airway resistance syndrome.
        Eur Respir J. 1997; 10: 2573-2577
        • Younes M.
        • Ostrowski M.
        • Thompson W.
        • et al.
        Chemical control stability in patients with obstructive sleep apnea.
        Am J Respir Crit Care Med. 2001; 163: 1181-1190
        • Edwards B.A.
        • Sands S.A.
        • Owens R.L.
        • et al.
        Effects of hyperoxia and hypoxia on the physiological traits responsible for obstructive sleep apnoea.
        J Physiol. 2014; 592: 4523-4535
        • Kearley R.
        • Wynne J.W.
        • Block A.J.
        • et al.
        The effect of low flow oxygen on sleep-disordered breathing and oxygen desaturation. A study of patients with chronic obstructive lung disease.
        Chest. 1980; 78: 682-685
        • Smith P.L.
        • Haponik E.F.
        • Bleecker E.R.
        The effects of oxygen in patients with sleep apnea.
        Am Rev Respir Dis. 1984; 130: 958-963
        • Wellman A.
        • Malhotra A.
        • Jordan A.S.
        • et al.
        Effect of oxygen in obstructive sleep apnea: role of loop gain.
        Respir Physiol Neurobiol. 2008; 162: 144-151
        • Edwards B.A.
        • Sands S.A.
        • Eckert D.J.
        • et al.
        Acetazolamide improves loop gain but not the other physiological traits causing obstructive sleep apnoea.
        J Physiol. 2012; 590: 1199-2111
        • Rajagopal K.R.
        • Abbrecht P.H.
        • Jabbari B.
        Effects of medroxyprogesterone acetate in obstructive sleep apnea.
        Chest. 1986; 90: 815-821
        • Moraes W.
        • Poyares D.
        • Sukys-Claudino L.
        • et al.
        Donepezil improves obstructive sleep apnea in Alzheimer disease: a double-blind, placebo-controlled study.
        Chest. 2008; 133: 677-683
        • Hedner J.
        • Grunstein R.
        • Eriksson B.
        • et al.
        A double-blind, randomized trial of sabeluzole–a putative glutamate antagonist–in obstructive sleep apnea.
        Sleep. 1996; 19: 287-289